Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-30 7:50 pm Purchase | 2026-06-24 | 13D | NANO DIMENSION LTD SPONSORED A NNDM | TANG CAPITAL MANAGEMENT LLC | 14,292,813 6.800% | 14,292,813 (New Position) | Filing History |
| 2026-06-29 7:58 pm Purchase | 2026-06-23 | 13G | BOUNDLESS BIO, INC. BOLD | TANG CAPITAL MANAGEMENT LLC | 2,533,845 11.300% | 2,533,845 (New Position) | Filing History |
| 2026-06-10 6:13 pm Purchase | 2026-06-03 | 13G | FULCRUM THERAPEUTICS INC FULC | TANG CAPITAL MANAGEMENT LLC | 5,451,800 8.200% | 5,451,800 (New Position) | Filing History |
| 2026-06-04 6:44 pm Purchase | 2026-06-02 | 13D | AURINIA PHARMACEUTICALS INC AUPH | TANG CAPITAL MANAGEMENT LLC | 13,044,106 10.000% | 814,606 (+6.66%) | Filing History |
| 2026-05-15 4:15 pm Purchase | 2026-03-31 | 13G | ALTIMMUNE INC ALT | TANG CAPITAL MANAGEMENT LLC | 666,022 0.300% | 666,022 (New Position) | Filing History |
| 2026-05-15 4:15 pm Purchase | 2026-03-31 | 13G | CRESCENT BIOPHARMA, INC CBIO | TANG CAPITAL MANAGEMENT LLC | 1,160,000 4.210% | 460,000 (+65.71%) | Filing History |
| 2026-05-15 4:15 pm Unchanged | 2026-03-31 | 13G | VENTYX BIOSCIENCES INC VTYX | TANG CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-05-13 4:15 pm Sale | 2026-05-11 | 13D | KEZAR LIFE SCIENCES INC NE KZR | TANG CAPITAL MANAGEMENT LLC | 0 0.000% | -664,314 (Position Closed) | Filing History |
| 2026-04-29 4:15 pm Purchase | 2026-04-22 | 13G | PURETECH HEALTH PLC ADS PRTCY | TANG CAPITAL MANAGEMENT LLC | 12,635,782 5.190% | 12,635,782 (New Position) | Filing History |
| 2026-04-01 4:14 pm Sale | 2026-03-30 | 13D | KEZAR LIFE SCIENCES INC NE KZR | TANG CAPITAL MANAGEMENT LLC | 664,314 9.000% | -55,686 (-7.73%) | Filing History |
| 2026-03-25 4:15 pm Unchanged | 2026-03-23 | 13D | AURINIA PHARMACEUTICALS INC AUPH | TANG CAPITAL MANAGEMENT LLC | 12,229,500 9.200% | 0 (Unchanged) | Filing History |
| 2026-03-03 5:30 pm Purchase | 2026-02-27 | 13D | AURINIA PHARMACEUTICALS INC AUPH | TANG CAPITAL MANAGEMENT LLC | 12,229,500 9.200% | 2,200,000 (+21.94%) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | ADICET BIO INC ACET | TANG CAPITAL MANAGEMENT LLC | 6,158 0.100% | -507,818 (-98.80%) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | CYBIN INC HELP | TANG CAPITAL MANAGEMENT LLC | 0 0.000% | -1,830,097 (Position Closed) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | TANG CAPITAL MANAGEMENT LLC | 0 0.000% | -11,065,662 (Position Closed) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | EVOLUS INC EOLS | TANG CAPITAL MANAGEMENT LLC | 1,245,692 1.920% | -3,751,707 (-75.07%) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | KEROS THERAPEUTICS INC KROS | TANG CAPITAL MANAGEMENT LLC | 0 0.000% | -2,418,984 (Position Closed) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | NKARTA INC NKTX | TANG CAPITAL MANAGEMENT LLC | 1,480,823 2.100% | -5,533,277 (-78.89%) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | PRECISION BIOSCIENCES INC DTIL | TANG CAPITAL MANAGEMENT LLC | 0 0.000% | -673,332 (Position Closed) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | TANG CAPITAL MANAGEMENT LLC | 1,892,200 2.400% | -1,307,800 (-40.87%) | Filing History |